DK0586592T3 - Insulin- og amylinholdig sammensætning til behandling af insulindeficiente pattedyr - Google Patents

Insulin- og amylinholdig sammensætning til behandling af insulindeficiente pattedyr

Info

Publication number
DK0586592T3
DK0586592T3 DK92913644T DK92913644T DK0586592T3 DK 0586592 T3 DK0586592 T3 DK 0586592T3 DK 92913644 T DK92913644 T DK 92913644T DK 92913644 T DK92913644 T DK 92913644T DK 0586592 T3 DK0586592 T3 DK 0586592T3
Authority
DK
Denmark
Prior art keywords
insulin
amylin
treatment
containing composition
deficient mammals
Prior art date
Application number
DK92913644T
Other languages
Danish (da)
English (en)
Inventor
Timothy J Rink
Andrew A Young
Original Assignee
Amylin Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amylin Pharmaceuticals Inc filed Critical Amylin Pharmaceuticals Inc
Application granted granted Critical
Publication of DK0586592T3 publication Critical patent/DK0586592T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK92913644T 1991-05-24 1992-05-23 Insulin- og amylinholdig sammensætning til behandling af insulindeficiente pattedyr DK0586592T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US70499591A 1991-05-24 1991-05-24
PCT/US1992/004351 WO1992020366A1 (en) 1991-05-24 1992-05-23 Insulin and amylin containing composition for the treatment of insulin deficient mammals

Publications (1)

Publication Number Publication Date
DK0586592T3 true DK0586592T3 (da) 2000-12-27

Family

ID=24831674

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92913644T DK0586592T3 (da) 1991-05-24 1992-05-23 Insulin- og amylinholdig sammensætning til behandling af insulindeficiente pattedyr

Country Status (11)

Country Link
EP (1) EP0586592B1 (de)
JP (1) JPH06510753A (de)
AT (1) ATE197764T1 (de)
AU (2) AU2169392A (de)
CA (1) CA2109604A1 (de)
DE (1) DE69231583T2 (de)
DK (1) DK0586592T3 (de)
ES (1) ES2153828T3 (de)
GR (1) GR3035287T3 (de)
SG (1) SG44838A1 (de)
WO (1) WO1992020366A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992020367A1 (en) * 1991-05-24 1992-11-26 Amylin Pharmaceuticals, Inc. Treatment of anorexia and related states
EP1196189A2 (de) 1999-06-25 2002-04-17 Medtronic MiniMed, Inc. Unterschiedliche wirkstoffe für diabetestherapie
AU2002248464A1 (en) 2001-02-21 2002-09-12 Medtronic Minimed, Inc. Stabilized insulin formulations
US6737401B2 (en) 2001-06-28 2004-05-18 Metronic Minimed, Inc. Methods of evaluating protein formulation stability and surfactant-stabilized insulin formulations derived therefrom

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8720115D0 (en) * 1987-08-26 1987-09-30 Cooper G J S Treatment of diabetes mellitus
GB8915712D0 (en) * 1989-07-08 1989-08-31 Macintyre Iain Medical treatment

Also Published As

Publication number Publication date
DE69231583T2 (de) 2001-03-29
GR3035287T3 (en) 2001-04-30
JPH06510753A (ja) 1994-12-01
DE69231583D1 (de) 2001-01-04
SG44838A1 (en) 1997-12-19
ATE197764T1 (de) 2000-12-15
EP0586592B1 (de) 2000-11-29
CA2109604A1 (en) 1992-11-26
AU2169392A (en) 1992-12-30
WO1992020366A1 (en) 1992-11-26
ES2153828T3 (es) 2001-03-16
AU6196496A (en) 1996-10-10
EP0586592A1 (de) 1994-03-16

Similar Documents

Publication Publication Date Title
HK1005705A1 (en) Use of rapamycin for the preparation of a medicament for the treatment of ocular inflammation
BG105079A (en) Glucagon-like peptide-1 improves beta-cell response to glucose in subjects with impaired glucose tolerance
ES2017471B3 (es) Aposito para el tratamiento de heridas y procedimiento de preparacion.
DK0670729T3 (da) Anvendelse af insulin-lignende vækstfaktorer og analoger til behandling af retinale nervesygdomme
EG19304A (en) Method of treating pre-menstrual syndrome
DE3889536D1 (de) Behandlung von krebs mit somatostatin und mit analogen davon.
CA2187803A1 (en) Methods of treating disease using sertoli cells and allografts or xenografts
GR3031129T3 (en) Enhancement of glutathione levels with glutamine
ES2174838T3 (es) Metodo para aumentar la absorcion del intestino.
EP0981360A4 (de) Verfahren zur prevention von gastritis unter verwedund von amylin oder amylin agonisten
DE69316013D1 (de) Verwendung von phosphinate zur behandlung der osteoporose
NO885023D0 (no) FremgangsmŸte for reduksjon av nitrogenoxydinnholdet i en avlsstr under anvendelse av sukker.
DK0586592T3 (da) Insulin- og amylinholdig sammensætning til behandling af insulindeficiente pattedyr
SG49239A1 (en) Amylin and possibly insulin containing composition for the treatment of aneroxia and related states
LV11987A (lv) Aptaukosanas noversanas vai arstesanas metode
ATE306278T1 (de) Behandlung von knochenleiden mit adrenomedullin
EP0335446A3 (de) Mittel zur Behandlung von Neoplasmen
DE69131058T2 (de) Verwendung einer therapeutischen Zusammensetzung zur Behandlung von Bronchitis
EP0260790A3 (de) Verwendung von Pinacidil zur Behandlung von Inkontinenz
ES8507552A1 (es) Un procedimiento para preparar 6-metilsulfonil-espiro-(croman-4,4'-imidazolidin)-2',5'-diona
KR910002455A (ko) 아크릴산 유도체를 함유하는 제약 조성물 및 의약으로서 이들의 사용
KR930700109A (ko) 신경 질환 치료용 4,4'-[9h-플루오렌-9-일리덴비스(메틸렌)]-비스피리미딘
IT1158026B (it) Prodotto coadiuvante per la profilassi e la terapia del cancro del seno, dopo mastectomia, costituito esclusivamente da un 17alfa-acilossi-6-metilpregna-4,6-diene-3,20-dione
SU1282383A1 (ru) Способ лечения туберкулеза наружных половых органов мужчин
UA28362A (uk) Спосіб лікування цукрового діабету в експерименті